Fingerprint
Dive into the research topics of 'Overall Survival With Second-Line Pembrolizumab in Patients With Non–Small-Cell Lung Cancer: Randomized Phase III Clinical Trial Versus Propensity-Adjusted Real-World Data'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically